ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
康休
65.60
0.0000
成交量:
- -
成交額:
- -
市值:
127.60億
市盈率:
-1.26
高:
65.60
開:
65.60
低:
65.60
收:
65.60
52周最高:
90.52
52周最低:
33.13
股本:
1.95億
流通股本:
1.92億
量比:
- -
換手率:
- -
股息:
0.73
股息率:
1.11%
每股收益(TTM):
-52.2669
每股收益(LYR):
-3.5480
淨資產收益率:
-77.91%
總資產收益率:
-30.69%
市淨率:
1.64
市盈率(LYR):
-18.49
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
港股互聯網、CXO方向有新催化!藥明生物、阿里巴巴低位反彈
每日经济新闻
·
昨天
美國生物科技法案未點名中國CXO!藥明生物漲超5%
每日经济新闻
·
昨天
醫藥外包概念普遍走高 藥明生物(02269)漲6.11% 機構看好看好CXO在業績和估值端迎來雙重修復
金吾财讯
·
昨天
為什麼有些頂級CEO很閒?
虎嗅APP
·
12/10
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/CXO"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CXO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CXO\",,,,,undefined,":{"symbol":"CXO","market":"US","secType":"STK","nameCN":"康休","latestPrice":65.6,"timestamp":1610744400000,"preClose":65.6,"halted":4,"volume":0,"delay":0,"floatShares":192489259,"shares":194506801,"eps":-52.266872,"marketStatus":"退市","change":0,"latestTime":"01-15 16:00:00 EST","open":65.6,"high":65.6,"low":65.6,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-52.266872,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1766394000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1186113600000,"exchange":"NYSE","adjPreClose":65.6,"dividendRate":0.011052,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CXO\",,,,,undefined,":{"symbol":"CXO","floatShares":192489259,"roa":"-30.69%","roe":"-77.91%","lyrEps":-3.548023,"shares":194506801,"dividePrice":0.725,"high":65.6,"amplitude":0,"preClose":65.6,"low":65.6,"week52Low":33.13,"pbRate":"1.64","week52High":90.52,"institutionHeld":0,"latestPrice":65.6,"eps":-52.266872,"divideRate":0.011052,"volume":0,"delay":0,"ttmEps":-52.266872,"open":65.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CXO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-01-19","symbol":"CXO","reason":null,"defaultRemindTime":1611066600000,"announcedDate":"2021-01-14","type":"delisting","dateTimestamp":1611032400000},{"market":"US","date":"2020-11-05","symbol":"CXO","amount":0.2,"defaultRemindTime":1604586600000,"name":"康休","payableDate":"2020-11-06","currency":"USD","type":"dividend","dateTimestamp":1604552400000},{"market":"US","date":"2020-10-27","symbol":"CXO","fiscalQuarterEnding":"2020/09","expectedEps":1.14,"name":null,"time":"盤後","type":"earning","dateTimestamp":1603771200000,"reportTimeType":"post","actualEps":1.43},{"market":"US","date":"2020-08-06","symbol":"CXO","amount":0.2,"defaultRemindTime":1596720600000,"name":"康休","payableDate":"2020-08-07","currency":"USD","type":"dividend","dateTimestamp":1596686400000},{"market":"US","date":"2020-07-29","symbol":"CXO","fiscalQuarterEnding":"2020/06","expectedEps":0.33,"name":null,"time":"盤後","type":"earning","dateTimestamp":1595995200000,"reportTimeType":"post","actualEps":1.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CXO\",market:\"US\",,,undefined,":[{"executeDate":"2019-02-28","recordDate":null,"paymentDate":null,"value":0.125,"currency":"USD"},{"executeDate":"2019-05-09","recordDate":"2019-05-10","paymentDate":null,"value":0.125,"currency":"USD"},{"executeDate":"2019-08-08","recordDate":"2019-08-09","paymentDate":null,"value":0.125,"currency":"USD"},{"executeDate":"2019-11-07","recordDate":"2019-11-08","paymentDate":null,"value":0.125,"currency":"USD"},{"executeDate":"2020-02-27","recordDate":"2020-02-28","paymentDate":null,"value":0.2,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CXO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CXO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CXO","date":"2021-01-15","current":-1.255097,"percent":0.244996,"low":-22.831021,"twenty":-14.937462,"median":17.448879,"eighty":43.624979,"high":142.858816,"avg":25.025998,"sd":38.430736,"marketCap":13577273687},"quantilePoints":[{"date":"2020-12-24","current":-1.091261,"twenty":-14.911606,"median":17.634394,"eighty":43.609716,"marketCap":11178881358},{"date":"2020-12-31","current":-1.106262,"twenty":-14.920934,"median":17.601937,"eighty":43.610988,"marketCap":11332549641},{"date":"2021-01-08","current":-1.237472,"twenty":-14.937462,"median":17.527755,"eighty":43.624979,"marketCap":12676660833},{"date":"2021-01-15","current":-1.325388,"twenty":-14.937462,"median":17.448879,"eighty":43.624979,"marketCap":13577273687}],"updateTime":1766228098576},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CXO\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2592134914","title":"港股互聯網、CXO方向有新催化!藥明生物、阿里巴巴低位反彈","url":"https://stock-news.laohu8.com/highlight/detail?id=2592134914","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592134914?lang=zh_tw&edition=fundamental","pubTime":"2025-12-19 11:17","pubTimestamp":1766114256,"startTime":"0","endTime":"0","summary":"港股科技两大核心资产——互联网、创新药低位反弹,港股通科技ETF基金涨1.5%,成分股药明生物涨超6%,药明合联涨超4%,腾讯、美团、阿里巴巴小幅上涨。相比恒生科技,国证港股通科技减配消费零售,增配了医药生物,以及硬件设备等,同时单一个股权重上限较高,更聚焦互联网+CXO龙头,因此指数弹性更大。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121911180097a07b68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121911180097a07b68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1515016050.SGD","BK4502","BK4614","LU0328353924.USD","LU0651947912.USD","LU1008478684.HKD","LU1105468828.SGD","LU1152091754.HKD","BK4533","IE00BFMHRM44.USD","LU0880133367.SGD","LU1051768304.USD","ALBmain","IE00BF5LJ272.USD","LU2226246903.HKD","BK4524","BK4558","LU0918141705.HKD","LU0553294199.USD","BK4579","BK4588","LU0072462343.USD","LU1267930227.SGD","BK4565","BK4503","LU1048588211.SGD","BK4505","CXO","BK4220","09988","BABA","LU0251143458.SGD","LU0821914370.USD","LU1242518857.USD","LU0106959298.USD","LU2148611432.USD","BK4548","LU0738911758.USD","BK4538","LU1242518931.SGD","LU0047713382.USD","LU1769817096.USD","BK4531","LU0052756011.USD","LU0501845795.SGD","LU1769817179.HKD","LU1003077747.HKD","LU1046422090.SGD","IE00B0JY6N72.USD","BK4534"],"gpt_icon":1},{"id":"2592310861","title":"美國生物科技法案未點名中國CXO!藥明生物漲超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592310861","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592310861?lang=zh_tw&edition=fundamental","pubTime":"2025-12-19 10:53","pubTimestamp":1766112795,"startTime":"0","endTime":"0","summary":"【美国生物科技法案未点名中国CXO!药明生物涨超5%】12月19日,港股科技板块展开反弹修复,恒生生物科技、港股通科技指数涨幅领先,两大指数共同的成分股药明生物涨超5%,药明合联涨超4%,信达生物、康方生物涨超2%。消息面上,美国当地时间12月18日,2026财年国防授权法案(2026NDAA)获通过,新版本生物安全法未具体点名任何一家公司,显著利好此前备受安全法案煎熬的中国CXO公司(药明康德和药明生物等)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512193596567879.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512193596567879.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0181495838.USD","LU0039217434.USD","BK1576","LU0516423174.USD","LU0572944931.SGD","LU0043850808.USD","LU0708995583.HKD","LU1794554557.SGD","LU0348825331.USD","LU0051755006.USD","02269","LU0823426480.USD","LU1880383366.USD","LU0456827905.SGD","LU1242518931.SGD","BK1521","LU0856984785.SGD","LU0516422366.SGD","LU0327786744.USD","LU0588546209.SGD","LU0979878070.USD","SG9999002562.SGD","LU0359202008.SGD","LU0516423091.SGD","BK1141","SG9999002463.SGD","LU0348735423.USD","LU0417516738.SGD","LU0823426308.USD","CXO","LU0320764599.SGD","159837","LU2039709279.SGD","BK1610","LU3063872942.SGD","LU0456846285.SGD","LU0516422440.USD","IE00B0JY6N72.USD","LU1242518857.USD","BK1589","LU0359201612.USD","LU0819121731.USD","LU0417516902.SGD","LU0140636845.USD","LU0326950275.SGD","LU1720050803.USD","LU0516422952.EUR","LU0052750758.USD","LU1688375341.USD","LU0307460666.USD"],"gpt_icon":0},{"id":"2592139047","title":"醫藥外包概念普遍走高 藥明生物(02269)漲6.11% 機構看好看好CXO在業績和估值端迎來雙重修復","url":"https://stock-news.laohu8.com/highlight/detail?id=2592139047","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592139047?lang=zh_tw&edition=fundamental","pubTime":"2025-12-19 10:26","pubTimestamp":1766111188,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药外包概念普遍走高,药明生物 涨6.11%,凯莱英升5.52%,康龙化成升4.69%,泰格医药升3.8%,维亚生物升3.72%,药明康德涨3.32%。世纪证券此前研报指出,本周NDAA法案落地,地缘风险趋于缓和。CXO业绩和新增订单开始好转,本周市场开始关注临床前安评试验资产食蟹猴。该机构认为CXO作为创新药产业链上游,行业经历过完整周期,有望受益于国产创新药竞争力提升带来的景气度回升,看好CXO在业绩和估值端迎来双重修复。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250110/MjA1YmE2ZTUwNGJlNDY3ODMxMDE0ODI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MjA1YmE2ZTUwNGJlNDY3ODMxMDE0ODI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971871","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516902.SGD","LU0823426480.USD","BK1161","BK1610","CXO","BK1583","LU0819121731.USD","LU0181495838.USD","LU0320764599.SGD","LU0051755006.USD","LU0052750758.USD","01873","06821","LU0516423174.USD","03347","IE00B0JY6N72.USD","LU0708995583.HKD","LU0348825331.USD","LU2125910500.SGD","02269","SG9999002463.SGD","LU0516422952.EUR","02359","BK1589","BK1576","LU1794554557.SGD","LU0140636845.USD","LU0516422366.SGD","LU2045819591.USD","LU0516423091.SGD","BK1521","09939","LU2242644610.SGD","03759","LU0359201612.USD","LU1720050803.USD","LU0039217434.USD","LU0456827905.SGD","LU0516422440.USD","BK1191","BK1574","LU0979878070.USD","LU0348735423.USD","LU1046422090.SGD","LU3063872942.SGD","SG9999002562.SGD","LU1242518931.SGD","LU1880383366.USD","159938","LU0043850808.USD"],"gpt_icon":0},{"id":"2590653902","title":"為什麼有些頂級CEO很閒?","url":"https://stock-news.laohu8.com/highlight/detail?id=2590653902","media":"虎嗅APP","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590653902?lang=zh_tw&edition=fundamental","pubTime":"2025-12-10 18:07","pubTimestamp":1765361220,"startTime":"0","endTime":"0","summary":"我也见过更多相反样子的企业家:那些把自己逼疯、同时也把团队逼疯,最终业绩却依然平平的CEO。为什么顶级CEO敢“闲”下来?回到我的朋友,这位厉害的年轻CEO看似“很闲”,实则是在做高杠杆的事情。我观察到,顶级CEO的日程表中,都会神圣不可侵犯地预留出“无干扰时间”。平台型/高科技轻资产:更依赖顶层架构设计和人才密度,CEO更应像一位“总架构师”,而非“工头”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MTQzMjE1NjQwMQ==&mid=2656136868&idx=1&sn=469d3631fb8da8d780e1e1f4c5235692&chksm=671b275db4bd1a32a8433d9f74e8f6be5eb9e926da6c9bb4c9cf83b1d53b3e3dd6ed55a6b3a5&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["CXO"],"gpt_icon":0}],"pageSize":4,"totalPage":18,"pageCount":1,"totalSize":72,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CXO\",params:#limit:6,delay:false,,,undefined,":[]}}